Navigation Links
Amgen Positioned to Deliver Attractive Growth Over Next Five Years
Date:11/7/2008

ration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

CONTACT: Amgen, Thousand Oaks

David Polk, (805) 490-0661 (media)

Arvind Sood, (805) 447-1060 (investors)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers
2. More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation
3. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
4. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
5. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
6. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
7. Amgen Announces Webcast of 2008 Third Quarter Financial Results
8. Amgens Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23
9. Call for Applications: The Amgen Award for Science Teaching Excellence
10. Amgen to Webcast 2008 Business Review Meeting on November 7 From Millennium Hotel in New York
11. New Therapy by Merck is Positioned to Earn Gold-Standard Status by 2011 in the Treatment of Chemotherapy-Induced Nausea and Vomiting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)...  Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... a privately held company based in ... a big data platform for centralized management and ... proprietary on-market Genomic Management Solution, Bina-GMS 1 , ... fast and scalable analyses to maximize the value ...
(Date:12/19/2014)... FL (PRWEB) December 18, 2014 ... the nation’s leading specialty pharmacies, has an expanded ... as clinical pharmacy consultants for prescriber offices in ... expertise. , “We have a variety of ... For example, those specializing in hepatitis C help ...
(Date:12/19/2014)... Reports from CDC show approximately ... one or more chronic health conditions - including cardiovascular ... some of these diseases, but may not eliminate the ... While implanted nerve stimulation devices today offer relief, they ... can induce side effects. , To eliminate the ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 With only ... time special on Sartorius Biohit products . The ... mLINE pipettes, Picus Electronic Pipette Trade-in Program, and free ... and Safety officers around the world. They are ideal ... Other features include:, ,     Full volume range ...
Breaking Biology Technology:Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2
... ATLANTA, Aug. 11 GeoVax Labs, Inc. (OTC,Bulletin ... human vaccines for diseases caused by HIV-1 (Human,Immunodeficiency ... results and provided an operational update for the ... for the Three Months and Six Months Ended ...
... /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex:,SVA), a vaccine-focused biotech ... 2007 Annual Meeting of Shareholders on Thursday, September 4,2008 ... held concurrently at,No. 39 Shangdi Xi Road, Haidian District, ... Antigua. All shareholders of record as of August 1,2008 ...
... Technology, Inc (OTC Bulletin Board: HFGB), a leading,developer ... materials,for use in pharmaceutical, nutraceutical and food production, ... agreement with DNP,International Co., Inc. of Santa Fe ... agreement Huifeng is to deliver 62 metric tons,of ...
Cached Biology Technology:GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update 2GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update 3GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update 4GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update 5GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update 6GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update 7GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update 8GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update 9GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update 10Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders 2Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc. 2
(Date:12/11/2014)... PAUL, Minn. , Dec. 10, 2014 /PRNewswire/ ... wireless physiologic monitoring, has released a new series ... needs of preclinical toxicology researchers. M series, part ... help toxicologists collect the best possible physiologic data ... Adding functional endpoints to toxicology studies ...
(Date:12/10/2014)... , Dec. 08, 2014 Research and ... the addition of the "Biometrics Market in ... http://photos.prnewswire.com/prnh/20130307/600769 ... projects such as rural banking and upgradation of ... trends witnessed in the market. Besides the aforementioned ...
(Date:12/3/2014)... 2, 2014   Marvin Test Solutions , ... solutions for military, aerospace, and manufacturing organizations, today ... successful TS-900 PXI semiconductor test platform . ... high-end systems to customers at a fraction of ... traditional ATE. "Our semiconductor customers ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... provider of scientific, technical and medical information products and ... study in Reproductive BioMedicine Online ... male couples and single men when using assisted reproduction ... single men using assisted reproduction assistance to have a ...
... an emerging treatment that aims to fight colorectal cancer ... the ESMO 15th World Congress on Gastrointestinal Cancer. ... called MGN1703 and suggest it may be possible to ... the treatment, reported Prof Hans-Joachim Schmoll from Martin Luther ...
... weeding out the bacteria that form the base of ... according to a new study. In climate change, ... atmospheric carbon dioxide levels and temperature rise globally, scientists ... which will perish in the environment of tomorrow. ...
Cached Biology News:Reproductive BioMedicine Online publishes study on assisted reproduction 2Immune-boosting colorectal cancer drug shows promise 2Greenhouse gas likely altering ocean foodchain 2
Human Presenilin-2 NTF Affinity Purified Polyclonal Ab...
2'-Fluorine-CTP (2'-F-CTP) is readily incorporated into transcripts by T7 and SP6 R&DNA™ Polymerase and is available separately....
Human Glypican 2 Biotinylated Affinity Purified PAb...
Tachykinin (H-2)...
Biology Products: